Medical Device | October 10, 2025
Integris Medtech files DRHP with SEBI for IPO
The company plans to use the funds raised from the net proceeds to repay or prepay certain loans
The company plans to use the funds raised from the net proceeds to repay or prepay certain loans
Panacea Biotec receives acceptance from CMSS for supply of bOPV
These products strengthen poultry immunity, improve productivity, and support sustainable farming practices~
States exhorted to ensure rational use of cough syrups, particularly among children, as most coughs are self-limiting and do not require pharmacological treatment
It represents a 30% increase in the company’s production capacity and introduces a segment dedicated to highly potent active ingredients
Early stage projects of up to Rs. 9 crore eligible for up to Rs. 5 crore assistance and later stage projects of up to Rs. 285 crore eligible for up to Rs. 100 crore assistance
The new algorithm will be introduced as part of Roche’s CKD Algorithm Panelon thenavify Algorithm Suite
The NDA submission follows the successful completion of a pivotal Phase III global clinical trial
Anti-microtubule binding region-tau antibody being investigated as a potential disease-modifying therapy to slow or delay progression of disease
Repatha is now the first and only PCSK9 inhibitor to demonstrate significant reduction of cardiovascular events as both primary and secondary prevention
Subscribe To Our Newsletter & Stay Updated
